Atlas Trials

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

Clinical trial NCT02701699 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02701699
Sponsor
University Health Network, Toronto
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2014-12-01
Primary completion
2027-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.